Navigation Links
Palatin Technologies to Present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference
Date:1/16/2012

CRANBURY, N.J., Jan. 16, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that Dr. Carl Spana, President and Chief Executive Officer will present at BOCEMb, Noble Financial Capital Markets' Eighth Annual Equity Conference.  The presentation is scheduled for Tuesday, January 17th, at 9:30 a.m. Eastern Time.  BOCEMb will be held at the Hard Rock Hotel in Hollywood, Florida.

A live audio and high-definition video webcast of Palatin's presentation and a copy of the presentation materials will be available through Noble Financial websites www.noblefcm.com or www.BOCEM2012.com.  To ensure timely access, it is recommended to register at least 10 minutes prior to the start of the presentation.  You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. A live audio broadcast only will also be available on the "Investors" section of Palatin's website at www.palatin.com.  The live audio broadcast will be available through January 24, 2012.

About Palatin Technologies

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
2. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
3. Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
4. FDA Clears Palatin Technologies IND Filing to Commence Clinical Studies for Asthma
5. Palatin Technologies, Inc. Closes $23 Million Public Offering
6. Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex
7. Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
8. Palatin Technologies to Present at 9th Annual BIO Investor Forum
9. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
10. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
11. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , congratulates ... from the U.S. FDA for ibalizumab (TMB355). The FDA ... is intended, alone or in combination with one or ...
(Date:2/27/2015)...  Following a bipartisan vote in the House ... the Medicare DMEPOS Competitive Bidding Improvement Act of ... released a statement praising the Committee,s work and ... "Today,s mark-up of the Competitive Bidding ... Committee is a critical step forward for this ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
(Date:3/1/2015)... 2015 A federal court overseeing ... scheduled to go to trial in October has ... to provide testimony regarding the role an Italian ... Profemur device, Bernstein Liebhard LLP comments. According to ... District of Iowa on February 25th, Wright Medical ...
(Date:3/1/2015)... 01, 2015 The number of transvaginal ... the past few weeks in two New Jersey litigations ... claims, the Firm announces. , A Case List ... the Bergen County proceeding established for products manufactured by ... few weeks earlier, when 90 fewer cases had been ...
(Date:3/1/2015)... 2015 ERISAPros is pleased ... Roddy to the professional staff of its Compliance Department. ... The Ohio State University-Mortiz College of Law. Prior to ... working with several Fortune 500 companies as well as ... corporate benefits. Her experiences range from benefit plan design, ...
(Date:3/1/2015)... Theme and plugin developers from Pixel Film ... for Final Cut Pro X entitled Transccordion. , “Transccordion ... FCPX editors project.” Said Christiana Austin, CEO of Pixel ... to easily drag and drop their accordion transition between ... controls over the parameters of this transition bundle and ...
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims ... platform and gears towards the goal for a better ... group talks in smaller groups will be held after ... Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and ... youths. , Young adults aged between 18-30 ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4
... 2011 Horst Sievert, MD, PhD, a renowned ... O. Hartzler Master Clinical Operator Award in a ... Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the ... given each year to a physician who has ...
... Nov. 11 (HealthDay News) -- Age-related declines in physical ... a new study. "The more income and assets ... co-author Virginia Richardson, a professor of social work at ... The researchers analyzed data from roughly 6,500 participants ...
... -- ,Helping others can reduce cravings for alcohol and ... study suggests. Such cravings are major causes of ... noted. The study included 93 male and 102 ... courts for substance abuse treatment at a large facility ...
... a new oral cholera vaccine developed through the ... by the United Nations and based in Seoul, ... (WHO). Developed for use in developing countries ... to use in a single-dose vial and is ...
... using stem cells, in the hope to replace damaged ... for application in other degenerative conditions. Drs Clare ... Florey Neuroscience Institutes and the University of Melbourne. They ... collaboration being launched at the University of Melbourne today. ...
... Although it can be prevented with a vaccine, roughly 90 ... flu each year, resulting in about 1 million hospital admissions, ... online edition of The Lancet , the research also ... 111,500 children in 2008. According to the report, 99 percent ...
Cached Medicine News:Health News:Horst Sievert, M.D., Ph.D. presented with Master Clinical Operator Award at TCT 2011 2Health News:Helping Others Helps Teens Beat Substance Abuse 2Health News:IVI announces the prequalification of innovative cholera vaccine by the World Health Organization 2Health News:IVI announces the prequalification of innovative cholera vaccine by the World Health Organization 3Health News:Stem cell research hopes to repair brain damage of Parkinson's disease 2Health News:Stem cell research hopes to repair brain damage of Parkinson's disease 3
... powder Moisture: 10% Ash: ... gm/cm 2 Gel pH (1.5%): 5.0 7.0 ... 80 95C A (430 nm, 1.5%): ... >= 25,000 Ohms EEO (-m r ): ...
...
... Chamber has been used worldwide for two ... gas mixture and temperature. This airtight chamber ... in vitro fertilization, HIV isolation, creation of ... organ culture and the culturing of a ...
... A wide range of miniTHERM incubators is ... appropriate application solution for their specific requirements. ... liters, are compact and extremely space saving. ... microwave oven. It is possible to stack ...
Medicine Products: